Albumin as a carrier system for delivering drugs to solid tumors.
Schlicker
A
A
Department of Pharmaceutical Technology, Friedrich Schiller University Jena, Germany.
Peschke
P
P
Sinn
H
H
Hahn
E W
EW
D000818:Animals; D001549:Benzamides / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000633:toxicity; D001682:Biological Availability; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D006224:Cricetinae; D004337:Drug Carriers / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000633:toxicity; D006801:Humans; D008297:Male; D009368:Neoplasm Transplantation; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000633:toxicity; D011877:Radionuclide Imaging; D051381:Rats; D011919:Rats, Inbred Strains; D012709:Serum Albumin / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000633:toxicity; D014018:Tissue Distribution
D001549:Benzamides; D004337:Drug Carriers; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011838:Radiation-Sensitizing Agents; D012709:Serum Albumin; C025160:3-aminobenzamide